Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 11601-11610 of 11953

Edit search filters
  1. A Study To Evaluate Heart Failure Biomarker To Predict Cardiomyopathy After Acute Radiation

    Jacksonville, FL

  2. Expanded Access Program (EAP): Allow Patients In The US With Idiopathic Pulmonary Fibrosis Access To Pirfenidone

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  3. A Study To Evaluate COVID-19 Testing Using Saliva

    Jacksonville, FL

  4. Study To Assess The Safety And Effectiveness Of Shingrix Vaccine In Patients With Hematologic Malignancies

    Rochester, MN

  5. SD Study

    Rochester, MN

  6. PROspective Registry Of Pancreatic Neuroendocrine Tumors (PROPNET)

    Rochester, MN

  7. Analysis Of Tumor And Immune Cells Isolated From Tissue And Urine Of Bladder Cancer Patients

    Jacksonville, FL, Rochester, MN

  8. Environmental And Genetic Risk Factors For Pediatric Multiple Sclerosis

    Rochester, MN

  9. A Study To Determine Number Of Patients Who Develop High Ammonia Levels After Receiving Recombinant Erwinia Asparaginase

    Rochester, MN

  10. A Prospective Registry Of Pediatric Cellular Therapy Patients At Risk For Endothelial Dysfunction, Sinusoidal Obstruction Syndrome And/or Multi-Organ Dysfunction Syndrome (MODS)

    Rochester, MN

.

Mayo Clinic Footer